Neosalvarsan

Neosalvarsan

<< >>
Usage conditions apply
Downloads
Description
Glass vial with paper label that reads in part “0.3 Gram / Lot No. / Neosalvarsan / Trade Mark Reg. U.S. Pat. Off. / BRAND OF NEOSALVARSAN / H. A. Metz Laboratories / New York, N.Y.” Neosalvarsan is a synthetic chemotherapeutic that became available in 1912 and superseded the more toxic and less water-soluble salvarsan as an effective treatment for syphilis. Both of compounds carried considerable risk of side effects, and were replaced by penicillin in the 1940s.
Herman August Metz (1867-1934) was a New Yorker of German descent who worked for several firms that manufactured and imported German dyestuffs, chemicals, and pharmaceuticals. In 1903 he established his own firm, H. A. Metz & Co.
Ref: “Neo-Salvarsan,” New York Times (May 20, 1912), p. 12.
Location
Currently not on view
Object Name
Pharmaceutical
pharmaceutical
Date made
ca. 1927-1932
maker
H.A. Metz Laboratories
place made
United States: New York, New York City
Measurements
overall: 8.5 cm x 1.8 cm; 3 3/8 in x 11/16 in
overall: 3 3/8 in x 3/4 in; 8.5725 cm x 1.905 cm
ID Number
2001.0314.214
accession number
2001.0314
catalog number
2001.0314.214
Credit Line
Gift of The History Factory
subject
Sterling Drug Collection
See more items in
Medicine and Science: Medicine
Data Source
National Museum of American History
Nominate this object for photography.   

Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.

If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.

Note: Comment submission is temporarily unavailable while we make improvements to the site. We apologize for the interruption. If you have a question relating to the museum's collections, please first check our Collections FAQ. If you require a personal response, please use our Contact page.